Login
Register
Complete Your Profile
Change Password
Request a Password Reset
Download Documents
Download Documents
Get Help to Participate in This Tender
Change Password
For better security, update the account password.
The IRCCS FOUNDATION BESTA NEUROLOGICAL INSTITUTE has issued a Tender notice for the procurement of a Specific Contract for the Supply of the Drug Soliris 300Mg (Active Ingredient Eculizumab), through the Use of the Sintel - Sda Platform in the Italy. This Tender notice was published on 28 Aug 2025 and is scheduled to close on 03 Sep 2025, with an estimated Tender value of EUR 1042688.00. Interested bidders can access detailed Tender information, eligibility criteria, and complete bidding documents by referencing TOT Ref No. 125278320, while the tender notice number is Besta_2025_205_PE and Registering on the platform.
Procurement Summary
Country: Italy
Summary: Specific Contract for the Supply of the Drug Soliris 300Mg (Active Ingredient Eculizumab), through the Use of the Sintel - Sda Platform
Deadline: 03 Sep 2025
Posting Date: 28 Aug 2025
Other Information
Notice Type: Tender
TOT Ref.No.: 125278320
Document Ref. No.: Besta_2025_205_PE
Competition: ICB
Financier: Self Financed
Purchaser Ownership: Public
Tender Value: EUR 1042688.00
Purchaser's Detail
Name: Login to see tender_details
Address: Login to see tender_details
Email: Login to see tender_details
Login to see detailsTender Details
Specific contract for the supply of the drug soliris 300mg (active ingredient Eculizumab), through the use of the Sintel - SDA platform
Earnest Money : 1.042.688, 00 €
Published Date : 27/08/2025
Submission Date : 03/09/2025 12:00
Documents
Procurement Documents for Italy
Access a comprehensive library of standard procurement documents specific to Italy. Here, you'll find all the essential forms, guidelines, and templates required for tender applications and submissions in Italy
Want To Bid in This Tender?
Get Local Agent Support in Italy and 60 More Countries.
View Tenders By
Sign in with Google